On May 18, 2012, Hospira issued a safety alert to healthcare professionals about potential, clinically significant volume overfill in prefilled Carpuject and iSecure syringe systems—more than twice ...

Hospira announced a nationwide voluntary recall of one lot of Morphine Sulfate injection, 4mg/mL, due to a customer report of two Carpujects syringes containing more than the 1mL labeled fill volume.

An investigation into user complaints of overfilled Carpuject syringes led Hospira ($HSP) to realize manufacturing problems with overfills were far more extensive ...

UNDATED - Hospira, Inc., a Pfizer company, is voluntarily recalling lots 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe ...

The batch was distributed between August 14, 2018 and September 5, 2018. Two lots of naloxone hydrochloride injections, USP have been recalled by Hospira, Inc., due to concerns regarding the presence ...

Pfizer notified customers Jan. 31 it is having difficulty making certain prefilled syringes of opioid painkillers — marking the third time in six months the company has encountered manufacturing ...

The FDA has announced a nationwide recall of the overdose antidote drug Naloxone. According to the FDA website, Hospira, Inc. is voluntarily recalling lots 72680LL and 76510LL of Naloxone ...

According to the FDA, Hospira, Inc., a Pfizer company is recalling lots 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe ...

One lot of hydromorphone HCI injection 1 mg/mL manufactured by Hospira (Dilaudid) is being recalled due to reports that the prefilled glass cartridges designed for use in the Carpuject Syringe system ...

Hospira ($HSP), which has been trying so hard to make improvements in its manufacturing and quality-control methods in the face of plant problems, has had to recall ...

Abbott Laboratories signed a definitive agreement to acquire parenteral products businesses from Sanofi Pharmaceuticals Inc. for $200 million. Abbott said it will receive worldwide rights to prefilled ...

ISMP can envision other problems not mentioned in response to the survey when using prefilled cartridges as vials. Nurses may want to dilute small volumes of IV push medications to aid slow ...